Advertisement

Advertisement

HK:1652 Stock Latest News

Fusen Pharmaceutical Sets Board Meeting to Review Interim Results and Dividend

Company AnnouncementsFusen Pharmaceutical Sets Board Meeting to Review Interim Results and Dividend

Fusen Pharma Wins Spot for Four Drugs in China’s Latest Centralised Procurement Round

PremiumCompany Announcements

Fusen Pharma Wins Spot for Four Drugs in China’s Latest Centralised Procurement Round

20d ago

Fusen Pharmaceutical Extends Completion Date for Henan Equity Transaction

PremiumCompany Announcements

Fusen Pharmaceutical Extends Completion Date for Henan Equity Transaction

24d ago

Fusen Pharmaceutical Wins China Approval for New Doxazosin Extended-Release Tablets

PremiumCompany Announcements

Fusen Pharmaceutical Wins China Approval for New Doxazosin Extended-Release Tablets

1M ago

Fusen Pharmaceutical Shareholders Approve RMB300 Million Capital Injection into Henan Subsidiary

PremiumCompany Announcements

Fusen Pharmaceutical Shareholders Approve RMB300 Million Capital Injection into Henan Subsidiary

2M ago

Fusen Pharmaceutical Wins China Nod for Peramivir Flu Injection

PremiumCompany AnnouncementsFusen Pharmaceutical Wins China Nod for Peramivir Flu Injection

2M ago

Fusen Pharmaceutical Seeks Shareholder Approval for RMB300 Million Capital Injection

Company Announcements

Fusen Pharmaceutical Seeks Shareholder Approval for RMB300 Million Capital Injection

2M ago

Fusen Pharmaceutical to Dilute Stake in Henan Unit via RMB300 Million Capital Increase

Company Announcements

Fusen Pharmaceutical to Dilute Stake in Henan Unit via RMB300 Million Capital Increase

2M ago

Fusen Pharmaceutical Sets July EGM to Approve Capital Increase Plan

PremiumCompany Announcements

Fusen Pharmaceutical Sets July EGM to Approve Capital Increase Plan

2M ago

Fusen Pharma Wins China Approval for New Piracetam Injection Formats

PremiumCompany Announcements

Fusen Pharma Wins China Approval for New Piracetam Injection Formats

2M ago

Fusen Pharmaceutical Wins China Nod to Market Agomelatine Antidepressant

PremiumCompany Announcements

Fusen Pharmaceutical Wins China Nod to Market Agomelatine Antidepressant

3M ago

Fusen Pharmaceutical Shareholders Approve All AGM Resolutions, Renew Capital Mandates

PremiumCompany Announcements

Fusen Pharmaceutical Shareholders Approve All AGM Resolutions, Renew Capital Mandates

3M ago

Fusen Pharmaceutical Wins China Approval for New Lornoxicam Injection

PremiumCompany AnnouncementsFusen Pharmaceutical Wins China Approval for New Lornoxicam Injection

3M ago

Fusen Pharmaceutical Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate

Company Announcements

Fusen Pharmaceutical Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate

4M ago

Fusen Pharma Wins Mainland China Approval for New Dydrogesterone Tablet

Company Announcements

Fusen Pharma Wins Mainland China Approval for New Dydrogesterone Tablet

4M ago

Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule

PremiumCompany Announcements

Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule

4M ago

Fusen Pharmaceutical Switches Auditor After Dispute Over 2025 Audit Fee

PremiumCompany Announcements

Fusen Pharmaceutical Switches Auditor After Dispute Over 2025 Audit Fee

5M ago

Fusen Pharmaceutical Narrows Annual Loss Despite Revenue Decline

PremiumCompany Announcements

Fusen Pharmaceutical Narrows Annual Loss Despite Revenue Decline

5M ago

Fusen Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results

PremiumCompany Announcements

Fusen Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results

5M ago

Fusen Pharmaceutical Wins China Approval for New Phosphate Injection

PremiumCompany AnnouncementsFusen Pharmaceutical Wins China Approval for New Phosphate Injection

8M ago

Fusen Pharmaceutical Replaces KPMG With CCTH as Auditor to Cut Costs

Company Announcements

Fusen Pharmaceutical Replaces KPMG With CCTH as Auditor to Cut Costs

8M ago

Fusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection

Company Announcements

Fusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >